Napo Therapeutics S.p.A.

About Napo Therapeutics S.p.A.

Napo Therapeutics is an independent European pharmaceutical company and a young startup led by a team of experienced professionals. The company focuses on fostering reciprocal relationships with everyone they encounter and aims to be close to people.

Products & Services

Innovative Therapies:Focused on developing innovative therapies, particularly in the areas of rare diseases and oncology.

Rare Disease Treatments:Specialized treatments for rare diseases, including market access strategies and clinical development.

Oncology Treatments:Therapies targeting oncology, with a focus on rare hematological neoplasms and other cancer-related conditions.

Specialties

Rare Diseases Oncology Clinical Research Market Access Strategies Regulatory Affairs

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 7595000 MR: - FA: approximately €7 million FAN: 7595000	D: 2023-02-09 FD: 2023-02-09	2 investors

Private Placement Latest

2023-02-09

$7.6M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

L

Lisa Conte

Founder, President and CEO of Jaguar Health

N

Niccolò Caderni

G

Giovanni Maria Conti

Partner at Grimaldi Studio Legale

J

John Micek III

Board Member of Jaguar Health

J

Jonathan B. Siegel

Life Sciences Expert

M

Massimo Radaelli

Manager and Pharmaceutical Entrepreneur with over 35 years of experience in the Bio-Pharmaceutical sector and dedicated to innovation in therapies for Rare Diseases and in Oncology

View 10 more team members with Pro

Unlock Full Team Directory

Recent News